Biological determinants of propranolol disposition in normal subjects and patients with cirrhosis [proceedings]. 1977

R A Branch, and D M Kornhauser, and D G Shand, and G R Wilkinson, and A J Wood

UI MeSH Term Description Entries
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities

Related Publications

R A Branch, and D M Kornhauser, and D G Shand, and G R Wilkinson, and A J Wood
August 1985, Gut,
R A Branch, and D M Kornhauser, and D G Shand, and G R Wilkinson, and A J Wood
January 1980, Biopharmaceutics & drug disposition,
R A Branch, and D M Kornhauser, and D G Shand, and G R Wilkinson, and A J Wood
January 1983, Hepatology (Baltimore, Md.),
R A Branch, and D M Kornhauser, and D G Shand, and G R Wilkinson, and A J Wood
March 1983, Antimicrobial agents and chemotherapy,
R A Branch, and D M Kornhauser, and D G Shand, and G R Wilkinson, and A J Wood
September 1987, British journal of clinical pharmacology,
R A Branch, and D M Kornhauser, and D G Shand, and G R Wilkinson, and A J Wood
February 1979, British journal of clinical pharmacology,
R A Branch, and D M Kornhauser, and D G Shand, and G R Wilkinson, and A J Wood
September 1995, Clinical pharmacology and therapeutics,
R A Branch, and D M Kornhauser, and D G Shand, and G R Wilkinson, and A J Wood
October 1979, British journal of clinical pharmacology,
R A Branch, and D M Kornhauser, and D G Shand, and G R Wilkinson, and A J Wood
January 1987, International journal of clinical pharmacology, therapy, and toxicology,
R A Branch, and D M Kornhauser, and D G Shand, and G R Wilkinson, and A J Wood
January 1992, European journal of clinical pharmacology,
Copied contents to your clipboard!